The GATRA Program is an annual international award to foster a scientific network and also the knowledge in the use of Antithrombin as a therapeutic product. Proposals may include, but are not limited to: efficacy, mechanism of action, safety and tolerability, quality of life and pharmacoeconomics.

The Program offers 1 award of €50,000 to applicants whose proposals best match the program's objectives, as assessed by an independent review committee. GATRA aims to:

• Develop novel concepts on Antithrombin research.
• Encourage discovery of beneficial Antithrombin applications.
• Further investigate mechanisms of action or clinical effects in different indications.
• Establish new and long-lasting cooperation with participating scientists and clinicians.
• Strengthen and increase the existing network between researchers and the company.
• Foster relationships with KOLs in different fields.